The Secret Behind ResMed’s Market Surge—AI, Awareness, & Smarter Sleep Campaigns!

ResMed Inc. delivered a strong performance in the first quarter of fiscal year 2026, showcasing a robust operational and financial stance amidst challenging global market conditions. The company reported a 9% growth in revenue, or 8% in constant currency, reflecting significant contributions across its product portfolio. The U.S., Canada, and Latin American markets demonstrated high single-digit growth in device sales and double-digit growth in masks, contributing substantially to the overall revenue growth. Performance in Europe, Asia, and other regions also showed promise with high single-digit growth in devices, although mask sales in these regions saw slower growth due to tough comparisons from last year. The Residential Care Software (RCS) segment registered mid-single-digit growth, indicating moderate success but highlighting a potential need for strategic pivoting and prioritized investment in higher-growth, higher-margin areas.